IBB ETF (iShares Biotechnology ETF) is managed by iShares by BlackRock (US) with $8.00B in net assets. IBB expense ratio is 0.44%, holding 259 positions across sectors including Health Care, Unknown, Information Technology. Inception date: 2001-02-05.

IBB performance shows a YTD return of 2.82%. The 1-year return is 41.76% and the 5-year return is 2.84%. IBB dividend yield stands at 0.23%, paid quarterly.

IBB top holdings include Gilead Sciences Inc (7.8%), Amgen Inc. (7.5%), Vertex Pharmaceuticals Inc (7.4%), Regeneron Pharmaceuticals, Inc. (7.2%), Alnylam Pharmaceuticals Inc. (4.0%). View all IBB holdings, sector breakdown, or dividend history.

IBB can be compared against other funds using the overlap calculator or side-by-side comparison tool. IBB alternatives are available via the screener, along with tax-loss harvesting opportunities.